Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

My Month Of Scanxiety

December 9th 2018, 11:20pm

Article

Four years' worth of high-stakes scans have made me an expert in four excellent ways to ease intense anxiety.

Stumbling Through The Holidays

December 4th 2018, 7:16pm

Article

Emotions are not an either/or proposition when it comes to metastatic cancer.

'Setting the Stage' in Breast Cancer

November 2nd 2018, 9:30pm

Article

Additional factors now help determine a breast cancer’s stage, making prognoses more accurate.

Turning Up The Volume

October 30th 2018, 9:10pm

Article

Metastatic breast cancer advocate goes to Washington DC to tell her own story and push for more research to be directed toward metastatic disease

Post-Mastectomy Tattooing: A Personal Decision

October 29th 2018, 11:42pm

Video

For some breast cancer survivors, 3D nipple tattooing is the right choice. Others may turn to body art or choose to do nothing at all.

FDA Approves Talzenna for Breast Cancer Treatment

October 16th 2018, 8:01pm

Article

With this FDA action, Talzenna (talazoparib) is the second PARP inhibitor to be approved in the breast cancer space.

A Few Thoughts On Olivia Newton-John

September 12th 2018, 8:52pm

Article

The words celebrities use carry an enormous amount of weight.

Finding Balance in the Extremes Of Cancer

September 10th 2018, 5:11pm

Article

A few thoughts and simple methods for finding a way to get back to the center of a life that includes all the emotions

Are We Tying Scientists' Hands?

August 27th 2018, 7:16pm

Article

Positive results, clinical utility, curtailed curiosity – has the desire for good news slowed the path to a cure?

PARP Inhibitor May Prolong Survival in Metastatic, BRCA-positive Breast Cancer

August 21st 2018, 12:28am

Article

Talazoparib reduced the risk for disease progression or death by 46 percent and improved quality of life compared with chemotherapy in a subgroup of women with breast cancer, according to the phase 3 EMBRACA trial results.